{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:29Z","timestamp":1786112789643,"version":"build-2736575974"},"reference-count":92,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008327","name":"Zhejiang University of Technology","doi-asserted-by":"publisher","award":["2024124"],"award-info":[{"award-number":["2024124"]}],"id":[{"id":"10.13039\/501100008327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22177105"],"award-info":[{"award-number":["22177105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21877101"],"award-info":[{"award-number":["21877101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017599","name":"Science and Technology Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2018R01015"],"award-info":[{"award-number":["2018R01015"]}],"id":[{"id":"10.13039\/501100017599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY19B020008"],"award-info":[{"award-number":["LY19B020008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.drudis.2026.104640","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:49:00Z","timestamp":1773215340000},"page":"104640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PHGDH: a metabolic switch in tumor drug resistance and a therapeutic target"],"prefix":"10.1016","volume":"31","author":[{"given":"Song-Song","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4223-7191","authenticated-orcid":false,"given":"Guo-Wu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104640_b0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12862-018-1309-8","article-title":"Classification, substrate specificity and structural features of D-2-hydroxyacid dehydrogenases: 2HADH knowledgebase","volume":"18","author":"Matelska","year":"2018","journal-title":"BMC Evol Biol"},{"key":"10.1016\/j.drudis.2026.104640_b0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-1119(00)00009-3","article-title":"Nucleotide sequence and differential expression of the human 3-phosphoglycerate dehydrogenase gene","volume":"245","author":"Cho","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.drudis.2026.104640_b0015","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/524101","article-title":"Phosphoglycerate dehydrogenase: potential therapeutic target and putative metabolic oncogene","volume":"2014","author":"Zogg","year":"2014","journal-title":"J Oncol"},{"key":"10.1016\/j.drudis.2026.104640_b0020","first-page":"5869","article-title":"Knockdown of PHGDH potentiates 5-FU cytotoxicity in gastric cancer cells via the Bcl-2\/Bax\/caspase-3 signaling pathway","volume":"11","author":"Zhang","year":"2018","journal-title":"Int J Clin Exp Path"},{"key":"10.1016\/j.drudis.2026.104640_b0025","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1038\/s41467-019-12606-7","article-title":"Genome-wide CRISPR\/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC","volume":"10","author":"Wei","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104640_b0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jcmgh.2023.06.006","article-title":"ZEB1 transcriptionally activates PHGDH to facilitate carcinogenesis and progression of HCC","volume":"16","author":"Wang","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.drudis.2026.104640_b0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-020-00196-w","article-title":"Targeting phosphoglycerate dehydrogenase in multiple myeloma","volume":"10","author":"Elsaadi","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.drudis.2026.104640_b0040","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.7150\/thno.23177","article-title":"Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2026.104640_b0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00018-021-04022-2","article-title":"Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors","volume":"79","author":"Tan","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.drudis.2026.104640_b0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.apsb.2021.06.008","article-title":"Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling","volume":"12","author":"Chen","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.drudis.2026.104640_b0055","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14465","article-title":"Inhibition of O6-methylguanine-DNA-methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT-proficient cells","volume":"103","author":"Akcora-Yildiz","year":"2024","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.drudis.2026.104640_b0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41374-021-00666-7","article-title":"Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O6-methylguanine DNA methyltransferase (MGMT) expression and reactive oxygen species (ROS)-mediated DNA damage in glioblastoma","volume":"102","author":"Jin","year":"2022","journal-title":"Lab Invest"},{"key":"10.1016\/j.drudis.2026.104640_b0065","article-title":"USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization","volume":"30","author":"Liu","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.drudis.2026.104640_b0070","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41467-023-36708-5","article-title":"PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104640_b0075","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/0008-5472.CAN-23-2266","article-title":"PRMT1 sustains de novo fatty acid synthesis by methylating PHGDH to drive chemoresistance in triple-negative breast cancer","volume":"84","author":"Yamamoto","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104640_b0080","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1038\/s41467-024-49087-2","article-title":"FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma","volume":"15","author":"Luo","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104640_b0085","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2174\/1871520619666190408142131","article-title":"Emerging role of CSN6 in biological behavior and cancer progress","volume":"19","author":"Mao","year":"2019","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/biom9060224","article-title":"Role of Cop9 signalosome subunits in the environmental and hormonal balance of plant","volume":"9","author":"Singh","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2026.104640_b0095","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1158\/0008-5472.CAN-22-2145","article-title":"CSN6 mediates nucleotide metabolism to promote tumor development and chemoresistance in colorectal cancer","volume":"83","author":"Zou","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104640_b0100","article-title":"Multifaceted roles of chemokine C-X-C motif ligand 7 in inflammatory diseases and cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2026.104640_b0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41419-025-07712-y","article-title":"Chemotherapy-induced macrophage CXCL7 expression drives tumor chemoresistance via the STAT1\/PHGDH-serine metabolism axis and SAM paracrine feedback to M2 polarization","volume":"16","author":"Liu","year":"2025","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.drudis.2026.104640_b0110","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1038\/s41467-022-32272-6","article-title":"Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers","volume":"13","author":"Nyen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104640_b0115","article-title":"RFWD3 reprograms nucleotide metabolism through PHGDH to induce chemoresistance in osteosarcoma","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci"},{"key":"10.1016\/j.drudis.2026.104640_b0120","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s42255-021-00448-x","article-title":"Nuclear PHGDH protects cancer cells from nutrient stress","volume":"3","author":"Annibali","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.drudis.2026.104640_b0125","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.celrep.2018.07.086","article-title":"The NAD+ salvage pathway supports PHGDH-driven serine biosynthesis","volume":"24","author":"Murphy","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2026.104640_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12964-024-02016-8","article-title":"FOXC1-mediated serine metabolism reprogramming enhances colorectal cancer growth and 5-FU resistance under serine restriction","volume":"23","author":"Chen","year":"2025","journal-title":"Cell Commun Signaling"},{"key":"10.1016\/j.drudis.2026.104640_b0135","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/s41388-025-03374-4","article-title":"Interaction of PHGDH with IGF2BP1 facilitates m6A-dependent stabilization of TCF7L2 mRNA to confer multidrug resistance in gastric cancer","volume":"44","author":"Chen","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2026.104640_b0140","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/s41467-025-58714-5","article-title":"The spatial transcriptional activity of hepatic TCF7L2 regulates zonated metabolic pathways that contribute to liver fibrosis","volume":"16","author":"Ayala","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104640_b0145","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/jcp.30822","article-title":"DNA hypomethylation activation Wnt\/TCF7L2\/TDRD1 pathway promotes spermatogonial stem cell formation","volume":"237","author":"Gao","year":"2022","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.drudis.2026.104640_b0150","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1111\/cas.15509","article-title":"Ubiquitin-specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma","volume":"113","author":"Sun","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.drudis.2026.104640_b0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade4113","article-title":"Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway","volume":"15","author":"Zhang","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.drudis.2026.104640_b0160","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1158\/0008-5472.CAN-19-3020","article-title":"Serine biosynthesis is a metabolic vulnerability in IDH2-driven breast cancer progression","volume":"81","author":"Barnabas","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104640_b0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3892\/ol.2022.13608","article-title":"FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in vitro and in vivo","volume":"25","author":"Zhao","year":"2023","journal-title":"Oncol Lett"},{"key":"10.1016\/j.drudis.2026.104640_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101248","article-title":"Lactylation in cancer progression and drug resistance","volume":"81","author":"Sun","year":"2025","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drudis.2026.104640_b0175","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1186\/s12967-025-06773-z","article-title":"Lactate dehydrogenase a: a potential new target for tumor drug resistance intervention","volume":"23","author":"Wang","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.drudis.2026.104640_b0180","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202401399","article-title":"Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC","volume":"11","author":"Lu","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.drudis.2026.104640_b0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/antiox8110505","article-title":"Peroxiredoxin 6 down-regulation induces metabolic remodeling and cell cycle arrest in HepG2 cells","volume":"8","author":"Grueso","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.drudis.2026.104640_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100985","article-title":"Inhibition of phosphoglycerate dihydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells","volume":"70","author":"Wang","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drudis.2026.104640_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103798","article-title":"Clock gene ARNTL2 enhances 5-fluorouracil resistance in colon cancer by upregulating SLC7A11 to suppress ferroptosis","volume":"86","author":"Yang","year":"2025","journal-title":"Redox Biol"},{"key":"10.1016\/j.drudis.2026.104640_b0200","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1080\/15384101.2022.2099191","article-title":"LncRNA MINCR attenuates osteoarthritis progression via sponging miR-146a-5p to promote BMPR2 expression","volume":"21","author":"Li","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.drudis.2026.104640_b0205","first-page":"972","article-title":"LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107\/\u03b2-catenin","volume":"25","author":"Li","year":"2020","journal-title":"J BUON"},{"key":"10.1016\/j.drudis.2026.104640_b0210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jcmgh.2023.06.006","article-title":"ZEB1 transcriptionally activates PHGDH to facilitate carcinogenesis and progression of HCC","volume":"16","author":"Wang","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.drudis.2026.104640_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102210","article-title":"LncRNA TCL6 regulates miR-876-5p\/MYL2 axis to suppress breast cancer progression","volume":"53","author":"Liu","year":"2025","journal-title":"Transl Oncol"},{"key":"10.1016\/j.drudis.2026.104640_b0220","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12935-025-03704-2","article-title":"The miR-876-5p\/SOCS4\/STAT3 pathway induced the expression of PD-L1 and suppressed antitumor immune responses","volume":"25","author":"Peng","year":"2025","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.drudis.2026.104640_b0225","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1007\/s00210-024-03279-1","article-title":"Natural products and long noncoding RNA signatures in gallbladder cancer: a review focuses on pathogenesis, diagnosis, and drug resistance","volume":"397","author":"Elimam","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.drudis.2026.104640_b0230","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.3390\/ijms22084231","article-title":"Biochemical and biophysical characterization of recombinant human 3-phosphoglycerate dehydrogenase","volume":"22","author":"Murtas","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104640_b0235","first-page":"33","article-title":"Construction and characterization of Escherichia coli D-3-phosphoglycerate dehydrogenase mutants with feedback-inhibition relief","volume":"17","author":"Deng","year":"2016","journal-title":"Sheng Wu Gong Cheng Xue Bao (Chinese J Biotechnol)"},{"key":"10.1016\/j.drudis.2026.104640_b0240","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fmolb.2018.00110","article-title":"D-3-phosphoglycerate dehydrogenase","volume":"5","author":"Grant","year":"2019","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.drudis.2026.104640_b0245","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12672-024-01013-0","article-title":"Preclinical efficacy of CBR-5884 against epithelial ovarian cancer cells by targeting the serine synthesis pathway","volume":"15","author":"Gong","year":"2024","journal-title":"Discov Oncol"},{"key":"10.1016\/j.drudis.2026.104640_b0250","article-title":"PHGDH inhibitor CBR-5884 inhibits epithelial ovarian cancer progression via ROS\/Wnt\/\u03b2-catenin pathway and plays a synergistic role with PARP inhibitor olaparib","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid Med Cell Longevity"},{"key":"10.1016\/j.drudis.2026.104640_b0255","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nchembio.2070","article-title":"A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate","volume":"12","author":"Pacold","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2026.104640_b0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-020-00196-w","article-title":"Targeting phosphoglycerate dehydrogenase in multiple myeloma","volume":"10","author":"Elsaadi","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.drudis.2026.104640_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100985","article-title":"Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells","volume":"70","author":"Wang","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drudis.2026.104640_b0270","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1021\/acs.jmedchem.9b00718","article-title":"Intracellular trapping of the selective phosphoglycerate dehydrogenase (PHGDH) inhibitor BI-4924 disrupts serine biosynthesis","volume":"62","author":"Weinstabl","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0275","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1038\/s41467-022-30363-y","article-title":"Mitochondria preserve an autarkic one-carbon cycle to confer growth-independent cancer cell migration and metastasis","volume":"13","author":"Kiweler","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104640_b0280","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjae190.0320","article-title":"P0146 Phosphoglycerate dehydrogenase plays a vital role in ER-stress-related intestinal inflammation","volume":"19","author":"Yang","year":"2025","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.drudis.2026.104640_b0285","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.bmcl.2019.07.011","article-title":"Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells","volume":"29","author":"Mullarky","year":"2019","journal-title":"Biorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2026.104640_b0290","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chembiol.2016.11.013","article-title":"Rational design of selective allosteric inhibitors of PHGDH and serine synthesis with anti-tumor activity","volume":"24","author":"Wang","year":"2017","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2026.104640_b0295","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1038\/s41598-019-41187-0","article-title":"Anti-alcohol abuse drug disulfiram inhibits human PHGDH via disruption of its active tetrameric form through a specific cysteine oxidation","volume":"9","author":"Spillier","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104640_b0300","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bioorg.2019.02.037","article-title":"Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase","volume":"87","author":"Guo","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0305","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1039\/C9FO00394K","article-title":"Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH","volume":"10","author":"Zheng","year":"2019","journal-title":"Food Funct"},{"key":"10.1016\/j.drudis.2026.104640_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100572","article-title":"Dimerization of PHGDH via the catalytic unit is essential for its enzymatic function","volume":"296","author":"Xu","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0315","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s12276-024-01268-1","article-title":"PHGDH: a novel therapeutic target in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.drudis.2026.104640_b0320","doi-asserted-by":"crossref","first-page":"14892","DOI":"10.1074\/jbc.M414489200","article-title":"Crystal structure of Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase","volume":"280","author":"Dey","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0325","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1006\/jmbi.1999.2653","article-title":"Gleaning non-trivial structural, functional and evolutionary information about proteins by iterative database searches","volume":"287","author":"Aravind","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1016\/j.drudis.2026.104640_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113379","article-title":"A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism","volume":"217","author":"Zhao","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0335","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5089","article-title":"On the quaternary structure of human D\u20103\u2010phosphoglycerate dehydrogenase","volume":"33","author":"Riva","year":"2024","journal-title":"Protein Sci"},{"key":"10.1016\/j.drudis.2026.104640_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100572","article-title":"Dimerization of PHGDH via the catalytic unit is essential for its enzymatic function","volume":"296","author":"Xu","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0345","doi-asserted-by":"crossref","DOI":"10.1002\/arch.21751","article-title":"D-3-phosphoglycerate dehydrogenase from the silkworm Bombyx mori: Identification, functional characterization, and expression","volume":"106","author":"Yamamoto","year":"2021","journal-title":"Arch Insect Biochem Physiol"},{"key":"10.1016\/j.drudis.2026.104640_b0350","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD+ metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104640_b0355","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","article-title":"NAD+ homeostasis in health and disease","volume":"2","author":"Katsyuba","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.drudis.2026.104640_b0360","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1021\/cr5004248","article-title":"New facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases","volume":"115","author":"Ryu","year":"2015","journal-title":"Chem Rev"},{"key":"10.1016\/j.drudis.2026.104640_b0365","doi-asserted-by":"crossref","first-page":"104478","DOI":"10.18632\/oncotarget.22327","article-title":"Structural insights into the enzymatic activity and potential substrate promiscuity of human 3-phosphoglycerate dehydrogenase (PHGDH)","volume":"8","author":"Unterlass","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104640_b0370","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1021\/acs.jmedchem.6b01167","article-title":"Challenges and opportunities in the development of serine synthetic pathway inhibitors for cancer therapy","volume":"60","author":"Ravez","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0375","article-title":"Discovery of a new allosteric inhibitor for human dopamine transporter by physics-based modeling and experimental validation","volume":"303","author":"Ye","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0380","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1158\/1538-7445.AM2025-6675","article-title":"Abstract 6675: exploiting rewired metabolism in cancer: a biochemical focus on malic enzyme inhibitors using structure-based drug design","volume":"85","author":"Krinkel","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104640_b0385","article-title":"Allosteric zinc inhibition and interdomain regulation govern the catalytic mechanism of the E3-independent ubiquitin-conjugating enzyme hUBE2O","volume":"302","author":"Xiang","year":"2025","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0390","doi-asserted-by":"crossref","first-page":"21178","DOI":"10.1021\/jacs.0c10418","article-title":"Recifin A, initial example of the Tyr-Lock peptide structural family, is a selective allosteric inhibitor of tyrosyl-DNA phosphodiesterase I","volume":"143","author":"Krumpe","year":"2020","journal-title":"JACS"},{"key":"10.1016\/j.drudis.2026.104640_b0395","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1073\/pnas.1521548113","article-title":"Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers","volume":"113","author":"Mullarky","year":"2016","journal-title":"PNAS"},{"key":"10.1016\/j.drudis.2026.104640_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115429","article-title":"Homoharringtonine as a PHGDH inhibitor: unraveling metabolic dependencies and developing a potent therapeutic strategy for high-risk neuroblastoma","volume":"166","author":"Hsieh","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104640_b0405","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.apsb.2021.06.008","article-title":"Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling","volume":"12","author":"Chen","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.drudis.2026.104640_b0410","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.3390\/molecules27186108","article-title":"Identification of novel natural inhibitors to human 3-phosphoglycerate dehydrogenase (PHGDH) for cancer treatment","volume":"27","author":"Sadiqa","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2026.104640_b0415","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chembiol.2016.11.013","article-title":"Rational design of selective allosteric inhibitors of PHGDH and serine synthesis with anti-tumor activity","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2026.104640_b0420","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.drudis.2016.04.023","article-title":"An improved model for fragment-based lead generation at AstraZeneca","volume":"21","author":"Fuller","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104640_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105705","article-title":"Discovery of PHGDH inhibitors by virtual screening and preliminary structure-activity relationship study","volume":"121","author":"Zhang","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0430","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acs.jmedchem.2c01202","article-title":"Discovery of novel drug-like PHGDH inhibitors to disrupt serine biosynthesis for cancer therapy","volume":"66","author":"Gao","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105159","article-title":"Discovery of novel inhibitors of human phosphoglycerate dehydrogenase by activity-directed combinatorial chemical synthesis strategy","volume":"115","author":"Zhou","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0440","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11696-020-01188-0","article-title":"Synthesis and biological evaluation of innovative thiourea derivatives as PHGDH inhibitors","volume":"74","author":"Xiang","year":"2020","journal-title":"Chem Pap"},{"key":"10.1016\/j.drudis.2026.104640_b0445","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/acs.jmedchem.6b01166","article-title":"\u03b1-Ketothioamide derivatives: a promising tool to interrogate phosphoglycerate dehydrogenase (PHGDH)","volume":"60","author":"Ravez","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104640_b0450","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/ph13020020","article-title":"Structure-activity relationships (SARs) of \u03b1-ketothioamides as inhibitors of phosphoglycerate dehydrogenase (PHGDH)","volume":"13","author":"Spillier","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drudis.2026.104640_b0455","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/molecules26020477","article-title":"Unravelling the allosteric targeting of PHGDH at the ACT-binding domain with a photoactivatable diazirine probe and mass spectrometry experiments","volume":"26","author":"Spillier","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2026.104640_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107330","article-title":"Identification of benzo b thiophene-1,1-dioxide derivatives as novel PHGDH covalent inhibitors","volume":"146","author":"Cao","year":"2024","journal-title":"Bioorg Chem"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:19:22Z","timestamp":1785946762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1359644626000450"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104640","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PHGDH: a metabolic switch in tumor drug resistance and a therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104640"}}